A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis
Public ClinicalTrials.gov record NCT06527404. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, 52-Week, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab in Adult Subjects With Prurigo Nodularis Who Are Inadequately Controlled on Topical Therapies or Not Eligible for Topical Therapies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PRO) measure of pruritus and overall clinical assessment score (US only).
Study identification
- NCT ID
- NCT06527404
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 469 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 18, 2024 (Actual)
- Primary completion
- Apr 17, 2026 (Actual)
- Completion
- Jun 25, 2026 (Actual)
- Last update posted
- Jul 27, 2026
2024 – 2026
United States locations
- U.S. sites
- 24
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Los Angeles Universal Research Center | Los Angeles | California | 90057 | — |
| Paradigm Clinical Research Center Inc | San Diego | California | 92108 | — |
| Wolverine Clinical Trials | Santa Ana | California | 92706 | — |
| Direct Helpers Research Center | Hialeah | Florida | 33012 | — |
| Southern Clinical Research | Miami | Florida | 33125 | — |
| University of Miami Hospital | Miami | Florida | 33125 | — |
| Miami Dermatology and Laser Institute | Miami | Florida | 33173 | — |
| Wellness Clinical Research | Miami Lakes | Florida | 33016 | — |
| Clinical Research Trials of Florida Inc | Tampa | Florida | 33607 | — |
| Olympian Clinical Research - Tampa | Tampa | Florida | 33615 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Endeavor Health Clinical Trials Center | Skokie | Illinois | 60077 | — |
| The Indiana Clinical Trials Center PC | Plainfield | Indiana | 46168 | — |
| Revival Research Institute, LLC | Troy | Michigan | 48084 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10028 | — |
| Optima Research | Boardman | Ohio | 44512 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Wright State Physicians | Fairborn | Ohio | 45324 | — |
| Hightower Clinical | Oklahoma City | Oklahoma | 73102 | — |
| Center For Clinical Studies PLLC | Houston | Texas | 77004 | — |
| Clarity Dermatology | Lancaster | Texas | 75146 | — |
| Springville Dermatology | Springville | Utah | 84663 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 168 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06527404, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06527404 live on ClinicalTrials.gov.